‘No deviations from the provisions of TRIPS’ Nov 1, 2012 Dr P Murali, President, ABLE & CEO, Evolva Biotech
’Need innovation policy wider than a Patent Act’ Nov 1, 2012 Leena Menghaney, India Campaign Manager Access Campaign Médecins Sans Frontières
’Law has a strong element of public policy’ Nov 1, 2012 Prof Raghavendra Lal Saha headed the Patent Facilitating Centre, TIFAC for many years starting from its inception and has been a…
’India yet to benefit from the new patent system’ Nov 1, 2012 Reji K Joseph is a consultant with Research and Information System for Developing Countries(RIS), a think tank with Government of…
’Failed to promote, nurture innovation’ Nov 1, 2012 Anay Shukla, Member, Pharma & Life Science team, Nishith Desai Associates
’Discourages the ’art of ever-greening” Nov 1, 2012 Dr Gopakumar G Nair was the Dean of Institute of Intellectual Property Studies (IIPS) at Hyderabad, India. Presently he heads his…
’Strike a balance between public & private interest’ Nov 1, 2012 Raghu Cidambi was legal affairs advisor to Dr Reddy Laboratories prior to joining IPA as an Advisor. A graduate from Indian…
‘Helps decide on right of monopoly to innovation’ Nov 1, 2012 Priyanka Gupta is Solution Consultant with the IP & Science business of Thomson Reuters. She provides intellectual property…
The price of innovation: Which way pharma? Nov 1, 2012 Are the high prices set by pharmaceutical companies for their products justifiable, asks Adefemi Adenuga, GlobalData's analyst…
’Collaborative commercialisation of incremental innovation could help bring affordable new… Nov 1, 2012 Tapan Ray, Director General, OPPI
‘The need of the hour is product innovation’ Nov 1, 2012 Anjan Sen, Director, Deloitte Touche Tohmatsu India
‘Non-working of patent a blot on knowledge economy’ Nov 1, 2012 Milind Sathe, Deputy General Manager – Projects, Unichem Laboratories
Can indian SMEs address healthcare solutions? Nov 1, 2012 Can Indian SMEs pursue passion and profit to address healthcare solutions? While emerging enterprises may lack access to deep…
’Indian innovation – Stay the course’ Nov 1, 2012 Nick Mitchell is part of the management team of Phenomenex India. He has been travelling to India on behalf of Phenomenex for…
’We are sure that Indian IP laws would favour innovation and protection of IP’ Nov 1, 2012 Dr PM Murali, President, ABLE and Managing Director and CEO, Evolva India describes to Express Pharma the potential of the…
Pricing it right Oct 20, 2012 The long pending decision on drug price policy finally seems to be coming to a conclusion, thanks to a firm push from the Supreme…
’Unless an ethics committee is accredited, it should not function’ Oct 20, 2012 In a high level meeting held at the Apollo Group of Hospitals, Delhi, experts from various institutions, deliberated on the need…
Long way to go for AYUSH Oct 6, 2012 The proposal to set up a separate arm of the CDSCO to scrutinise applications meeting AYUSH specifications has received mixed…
Pernicious osteoporosis Oct 6, 2012 Osteoporosis is a condition that results in loss of bone strength and density, causing bones to become more fragile and easily…